Gallacher Capital Management LLC Has $1.31 Million Holdings in HCA Healthcare, Inc. $HCA

Gallacher Capital Management LLC boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 89.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,760 shares of the company’s stock after acquiring an additional 1,305 shares during the quarter. Gallacher Capital Management LLC’s holdings in HCA Healthcare were worth $1,306,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Brighton Jones LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC grew its position in HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC lifted its position in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares in the last quarter. Jump Financial LLC bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. boosted its position in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

NYSE:HCA opened at $385.71 on Friday. The firm has a market cap of $85.57 billion, a price-to-earnings ratio of 13.26, a P/E/G ratio of 1.25 and a beta of 1.12. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The firm’s 50-day simple moving average is $393.51 and its 200 day simple moving average is $457.65.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.77 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

Analysts Set New Price Targets

HCA has been the topic of several analyst reports. KeyCorp dropped their price target on shares of HCA Healthcare from $510.00 to $475.00 and set an “overweight” rating on the stock in a research report on Tuesday. TD Cowen dropped their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Wells Fargo & Company dropped their price objective on HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating on the stock in a research note on Monday. Deutsche Bank Aktiengesellschaft cut their price target on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a report on Tuesday, April 28th. Finally, Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research note on Tuesday. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $486.14.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Some analysts remain constructive, with one Seeking Alpha piece arguing HCA’s recent underperformance may already reflect the biggest policy and margin concerns, and that the stock could be set up for a rebound if fundamentals stabilize.
• Neutral Sentiment: Barclays lowered its price target on HCA Healthcare from $427 to $402 and kept an equal-weight rating, signaling a more cautious near-term view even though the new target still implies modest upside from current levels. Barclays Cuts HCA Price Target
• Neutral Sentiment: Several articles noted that HCA’s stock still looks discounted relative to its long-term earnings power, but valuation arguments may be offset by growing concerns around reimbursement pressure and insurance coverage losses.
• Negative Sentiment: HCA cut its 2026 earnings outlook after reporting that federal policy changes, a worsening payer mix, and more uninsured patients could reduce profits by roughly $1 billion, raising concerns about margin compression and slower growth. HCA Cuts 2026 Earnings Forecast
• Negative Sentiment: Reports also highlighted a $400 million hit linked to policy changes and weaker earnings quality, since part of the quarterly beat was helped by a one-time Medicaid payment rather than underlying operating strength.
• Negative Sentiment: Labor and contract issues at one HCA hospital added another headline risk, though this appears less material than the company’s earnings and policy-related pressures.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.